Summary:
The study will measure the effectiveness of NSI-189 for the treatment of depression.
Qualified Participants Must:
Be between 18 and 60 years of age (Adult)
Have a diagnosis of major depressive disorder
Qualified Participants May Receive:
Study-related medical care and investigational drug at no cost and may be compensated for time and travel.